Hypertension Diagnostics, Inc. (HDII)
OTCMKTS · Delayed Price · Currency is USD
0.000001
0.00 (0.00%)
At close: Oct 16, 2026
Hypertension Diagnostics Market Cap
Hypertension Diagnostics has a market cap or net worth of $285 as of October 16, 2026. It is the 52,698th most valuable company in the world and the 8,685th biggest in the United States. Its market cap has decreased by 99.00% in one year.
Market Cap
285.00
Enterprise Value
n/a
Revenue
3.79M
Global Rank
Country Rank
#8,685 United States
PE Ratio
n/a
ChartMarket Cap Chart
Since August 7, 1998, Hypertension Diagnostics's market cap has decreased from 18.47M to 285.00, a decrease of -100.00%. That is a compound annual growth rate of -32.48%.
| Date | Market Cap | % Change |
|---|---|---|
| Oct 16, 2026 | 285.00 | - |
| Dec 31, 2025 | 285.00 | -99.90% |
| Dec 29, 2023 | 284.78K | -58.33% |
| Dec 30, 2022 | 683.48K | -61.03% |
| Dec 31, 2021 | 1.75M | -32.81% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 27, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| GIB Capital Group | 600.00 |
| Sulja Bros Building Supplies | 594.00 |
| Zhejiang Dashang Media | 521.00 |
| Calithera Biosciences | 487.00 |
| TPT Strategic | 401.00 |
| Perigee Holdings | 355.00 |
| Gambit Energy | 273.00 |
| Manaris (2010) | 204.00 |